drugset
drugset / Trial / NCT00904540

Topical Lidocaine Patch in Low Back Pain

NCT00904540 ↗

Phase 4 Completed 131 enrolled Endo USA Inc., a Keenova Therapeutics Company
Non-randomizedSingle-groupOpen-labelTreatment

Summary

Patients with acute or chronic Lower Back Pain (LBP) participated in a Phase IV clinical trial to assess the effectiveness of Lidoderm administered once daily (q24h) for 2 weeks in the treatment of acute and chronic LBP.

Timeline

Start
2002-03
Primary completion
2002-10
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 5 % Topical

Indications

No indication recorded.